BioSpace News Archive

Business

Bayer Acquires Noria, PSMA Therapeutics to Expand Place in Prostate Cancer Space

Bayer will nab exclusive rights to a differentiated alpha radionuclide, actinium-225 investigational compound, and a small molecule targeting prostate-specific membrane antigen.

June 4, 2021
·
2 min read
·
Brandon May
FDA

CVR Holders Slap BMS with Lawsuit After Missed Liso-Cel Deadline

It didn’t take too long before a lawsuit was filed over Bristol Myers Squibb’s failure to meet a deadline for a $9 Contingent Value Rights agreement tied to the company’s merger with Celgene.

June 4, 2021
·
2 min read
·
Alex Keown
Business

Three Biopharma Companies Raise Millions in Separate Series A Financing Rounds

The three companies will aim to develop their different programs such as Stablix TPS platform, Stellanova’s focused on targeting pro-tumorigenic effects, and Amyl’s development of preclinical therapeutic candidates.

June 4, 2021
·
3 min read
·
Alex Keown
Policy

HIV Epidemic: 40 Years Later

On June 5, the world marks the 40th anniversary of the HIV epidemic. Biopharma researchers continue to develop safe and effective treatments with an eye to a potential cure.

June 4, 2021
·
5 min read
·
Alex Keown
FDA

Novo Nordisk’s Wegovy is First and Only Once-Weekly GLP-1 Agonist Approved for Weight Management

Wegovy is the first and only once-weekly GLP-1 receptor agonist that’s been approved for weight control in people living with obesity. This is the same drug used to treat type 2 diabetes.

June 4, 2021
·
2 min read
·
Mark Terry
Genetown

Cellarity: Transforming Drug Development at the Confluence of Biology and Machine Learning

In the field of drug discovery, one must always begin with the target, right? Not if you ask Cellarity, a quickly emerging biotech company revolutionizing the drug development space.

June 4, 2021
·
5 min read
·
Heather McKenzie
Job Trends

Bayer at ASCO: Vitrakvi Effective in TRK Fusion Cancers Regardless of Tumor Type

Bayer, like many biopharma companies, is presenting study results at the 2021 American Society of Clinical Oncology (ASCO) Annual meeting being held online June 4-8, 2021.

June 4, 2021
·
5 min read
·
Mark Terry
Policy

FDA Action Alert: Alexion, Biogen, Vertex and Royalty

June is turning out to be a busy month for PDUFA dates for the U.S. Food and Drug Administration. Here’s a look at this week’s dates.

June 4, 2021
·
4 min read
·
Mark Terry
Drug Development

Another COVID-19 Win for Regeneron as FDA Okays Lower Dose of Antibody Cocktail

REGEN-COV’s 1,200 mg dose is authorized to treat mild-to-moderate COVID-19 in adults and children 12 years and older who weigh 40 kilograms or more.

June 4, 2021
·
2 min read
·
Mark Terry
Business

Global Acceptance for Sinovac’s COVID-19 Vaccine Grows Despite Disparate Data

While several countries rely on Sinovac Biotech to end the pandemic, concerns regarding the shot’s efficacy continue to shroud the vaccine. Currently, it is the second most used vaccine worldwide.

June 4, 2021
·
2 min read
·
Brandon May